Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;82(5):186-230.
doi: 10.1016/j.jinf.2020.12.007. Epub 2020 Dec 9.

Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study

Vanesa Agulló  1 , Marta Fernández-González  1 , Victoria Ortiz de la Tabla  2 , Nieves Gonzalo-Jiménez  3 , José A García  1 , Mar Masiá  4 , Félix Gutiérrez  5
Affiliations
Comment

Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study

Vanesa Agulló et al. J Infect. 2021 May.
No abstract available

Keywords: Antigen; Covid-19; Panbio; Rapid antigen test; Saliva, Nasal swab; Sars-cov-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

Figures

Fig. 1
Fig. 1
Performance of Panbio COVID-19 antigen Rapid Test Device in nasal, saliva and nasal + saliva samples according to the presence of symptoms and cycle threshold values. A: Performance in nasal samples. B: Performance in saliva samples. C: Performance in nasal + saliva samples. D: Performance in symptomatic patients according to cycle threshold values and days from symptom onset.
See this image and copyright information in PMC

Comment in

Comment on

  • Saliva is a reliable tool to detect SARS-CoV-2.
    Azzi L, Carcano G, Gianfagna F, Grossi P, Gasperina DD, Genoni A, Fasano M, Sessa F, Tettamanti L, Carinci F, Maurino V, Rossi A, Tagliabue A, Baj A. Azzi L, et al. J Infect. 2020 Jul;81(1):e45-e50. doi: 10.1016/j.jinf.2020.04.005. Epub 2020 Apr 14. J Infect. 2020. PMID: 32298676 Free PMC article.
  • Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.
    Iwasaki S, Fujisawa S, Nakakubo S, Kamada K, Yamashita Y, Fukumoto T, Sato K, Oguri S, Taki K, Senjo H, Sugita J, Hayasaka K, Konno S, Nishida M, Teshima T. Iwasaki S, et al. J Infect. 2020 Aug;81(2):e145-e147. doi: 10.1016/j.jinf.2020.05.071. Epub 2020 Jun 4. J Infect. 2020. PMID: 32504740 Free PMC article. No abstract available.

References

    1. Azzi L., Carcano G., Gianfagna F., et al. Saliva is a reliable tool to detect SARS-CoV-2. J Infect. 2020;81:e45–e50. doi: 10.1016/j.jinf.2020.04.005. [PMID: 32298676] - DOI - PMC - PubMed
    1. Iwasaki S., Fujisawa S., Nakakubo S., et al. Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva. J Infect. 2020;81:e145–e147. doi: 10.1016/j.jinf.2020.05.071. [PMID: 32504740] - DOI - PMC - PubMed
    1. La Marca A., Capuzzo M., Paglia T., et al. Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays. Reprod Biomed Online. 2020;41:483–499. doi: 10.1016/j.rbmo.2020.06.001. [PMID: 32651106] - DOI - PMC - PubMed
    1. Young S., Taylor S.N., Cammarata C.L., et al. Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS Antigen point-of-care test. J Clin Microbiol. 2020 doi: 10.1128/JCM.02338-20. [PMID: 330239] - DOI - PMC - PubMed
    1. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. Available at: https://www.who.int/publications/i/item/antigen-detection-in-the-diagnos....